Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process

NCT03922698 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT03922698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2019
Completion date
June 30, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid atherosclerosis